Molecular Targeted Therapy for Lung Cancer from a Pharmaceutical Point of Viewe Naho SASAKI epidermal growth factor receptor tyrosine kinase inhibitor :EGFR-TKI vascular endothelial growth factor:vegf mg ph ph phauc mg Cmax. AUC Key words
mg mg CYP A CYP A CYP A AUC CYP A AUC CYP A CYP A ph H ph INR PT-INR CYP A CYP A CYP A AUC CYP A CYP A AUC Cmax CYP AAUC in vitrougt A UGT A
H.. EGFR SPF..
.... PS PS..
mg/kg + +
. JO VEGFNO NONa / mmhg mmhg Common Terminology Critetia for Adverse Events Ver.. VEGF VEGF /..L
/. /. G-CSF.. EGFR-mutation.... Wacker B, Nagrani T, Weinberg J, et al:correlation between development of rash and efficacy in patients treated with the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in two large phase studies. Clin Cancer Ras,:-,... Sane DC, Brosnihan KB. Angiogenic growth factors and hypertension. Angiogegesis.: -,. Saif MW, Mehra R. Incidence and management of bevacizumabrelated toxicities in colorectal cancer. Expert Opin Drug Saf. : -,.